Efficacy and Safety of ETX-018810 in Subjects With Lumbosacral Radicular Pain

Summary

Efficacy and Safety of ETX 018810 in Subjects with Lumbosacral Radicular Pain

Timeline

Start

2021-01-19

Primary completion

2022-05-16

Completion

2022-05-25

Outcome

Missed primary endpoint

registry analysis (superiority test); ETX-018810 vs Placebo; p = 0.4549; Mean Difference (Final Values) 0.22 (95% CI -0.36 to 0.79); Mixed Models Analysis NCT04778592 ↗

Drugs

Indications